Greatbatch To Boost Cardiac And Neurostim Presence With Enpath Purchase
This article was originally published in The Gray Sheet
Executive Summary
Greatbatch hopes to expand its reach in the cardiac rhythm management and neurostimulation markets with a $102 million acquisition of Enpath announced April 30
You may also be interested in...
Greatbatch Becomes A Top Ortho Component Supplier With Precimed Buy
Device component maker Greatbatch's purchase of Precimed marks the firm's entrée into the orthopedic device sector and establishes Greatbatch as one of the top three suppliers to manufacturers of finished orthopedic devices, according to the firm
Greatbatch Becomes A Top Ortho Component Supplier With Precimed Buy
Device component maker Greatbatch's purchase of Precimed marks the firm's entrée into the orthopedic device sector and establishes Greatbatch as one of the top three suppliers to manufacturers of finished orthopedic devices, according to the firm
Greatbatch Capacitor Sales, Enpath Purchase Aid 27% Stock Price Jump In Q2
Greatbatch's recent surge in ICD capacitor sales and acquisition of implantable stimulation lead manufacturer Enpath helped drive a 27% jump in Greatbatch's stock price in the second quarter